|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lares MR, Rossi JJ and Ouellet DL: RNAi
and small interfering RNAs in human disease therapeutic
applications. Trends Biotechnol. 28:570–579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Castanotto D and Rossi JJ: The promises
and pitfalls of RNA-interference-based therapeutics. Nature.
457:426–433. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tiemann K and Rossi JJ: RNAi-based
therapeutics-current status, challenges and prospects. EMBO Mol
Med. 1:142–151. 2009. View Article : Google Scholar
|
|
5
|
Li LC, Okino ST, Zhao H, Pookot D, Place
RF, Urakami S, Enokida H and Dahiya R: Small dsRNAs induce
transcriptional activation in human cells. Proc Natl Acad Sci USA.
103:17337–17342. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Janowski BA, Younger ST, Hardy DB, Ram R,
Huffman KE and Corey DR: Activating gene expression in mammalian
cells with promoter-targeted duplex RNAs. Nat Chem Biol. 3:166–173.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Place RF, Li LC, Pookot D, Noonan EJ and
Dahiya R: MicroRNA-373 induces expression of genes with
complementary promoter sequences. Proc Natl Acad Sci USA.
105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Turunen MP, Lehtola T, Heinonen SE, Assefa
GS, Korpisalo P, Girnary R, Glass CK, Väisänen S and Ylä-Herttuala
S: Efficient regulation of VEGF expression by promoter-targeted
lentiviral shRNAs based on epigenetic mechanism: A novel example of
epigenetherapy. Circ Res. 105:604–609. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang V, Qin Y, Wang J, Wang X, Place RF,
Lin G, Lue TF and Li LC: RNAa is conserved in mammalian cells. PLoS
One. 5:e88482010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang J, Place RF, Huang V, Wang X, Noonan
EJ, Magyar CE, Huang J and Li LC: Prognostic value and function of
KLF4 in prostate cancer: RNAa and vector-mediated overexpression
identify KLF4 as an inhibitor of tumor cell growth and migration.
Cancer Res. 70:10182–10191. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Matsui M, Sakurai F, Elbashir S, Foster
DJ, Manoharan M and Corey DR: Activation of LDL receptor expression
by small RNAs complementary to a noncoding transcript that overlaps
the LDLR promoter. Chem Biol. 17:1344–1355. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang X, Wang J, Huang V, Place RF and Li
LC: Induction of NANOG expression by targeting promoter sequence
with small activating RNA antagonizes retinoic acid-induced
differentiation. Biochem J. 443:821–828. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang T, Li M, Yuan H, Zhan Y, Xu H, Wang
S, Yang W, Liu J, Ye Z and Li LC: saRNA guided iNOS up-regulation
improves erectile function of diabetic rats. J Urol. 190:790–798.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang K, Shen J, Xie YQ, Lin YW, Qin J, Mao
QQ, Zheng XY and Xie LP: Promoter-targeted double-stranded small
RNAs activate PAWR gene expression in human cancer cells. Int J
Biochem Cell Biol. 45:1338–1346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen Z, Place RF, Jia ZJ, Pookot D, Dahiya
R and Li LC: Antitumor effect of dsRNA-induced
p21WAF1/CIP1 gene activation in human bladder cancer
cells. Mol Cancer Ther. 7:698–703. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang K, Zheng XY, Qin J, Wang YB, Bai Y,
Mao QQ, Wan Q, Wu ZM and Xie LP: Up-regulation of
p21WAF1/Cip1 by saRNA induces G1-phase arrest and
apoptosis in T24 human bladder cancer cells. Cancer Lett.
265:206–214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Whitson JM, Noonan EJ, Pookot D, Place RF
and Dahiya R: Double stranded-RNA-mediated activation of P21 gene
induced apoptosis and cell cycle arrest in renal cell carcinoma.
Int J Cancer. 125:446–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei J, Zhao J, Long M, Han Y, Wang X, Lin
F, Ren J, He T and Zhang H: p21WAF1/CIP1 gene transcriptional
activation exerts cell growth inhibition and enhances
chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer.
10:6322010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Place RF, Wang J, Noonan EJ, Meyers R,
Manoharan M, Charisse K, Duncan R, Huang V, Wang X and Li LC:
Formulation of small activating RNA into lipidoid nanoparticles
inhibits xenograft prostate tumor growth by inducing p21
expression. Mol Ther Nucleic Acids. 1:e152012. View Article : Google Scholar :
|
|
20
|
Kang MR, Yang G, Place RF, Charisse K,
Epstein-Barash H, Manoharan M and Li LC: Intravesical delivery of
small activating RNA formulated into lipid nanoparticles inhibits
orthotopic bladder tumor growth. Cancer Res. 72:5069–5079. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Johnstone RW, Tommerup N, Hansen C,
Vissing H and Shi Y: Mapping of the human PAWR (par-4) gene to
chromosome 12q21. Genomics. 53:241–243. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sells SF, Wood DP Jr, Joshi-Barve SS,
Muthukumar S, Jacob RJ, Crist SA, Humphreys S and Rangnekar VM:
Commonality of the gene programs induced by effectors of apoptosis
in androgen-dependent and -independent prostate cells. Cell Growth
Differ. 5:457–466. 1994.PubMed/NCBI
|
|
23
|
Chakraborty M, Qiu SG, Vasudevan KM and
Rangnekar VM: Par-4 drives trafficking and activation of Fas and
Fasl to induce prostate cancer cell apoptosis and tumor regression.
Cancer Res. 61:7255–7263. 2001.PubMed/NCBI
|
|
24
|
Gurumurthy S, Goswami A, Vasudevan KM and
Rangnekar VM: Phosphorylation of Par-4 by protein kinase A is
critical for apoptosis. Mol Cell Biol. 25:1146–1161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goswami A, Burikhanov R, de Thonel A,
Fujita N, Goswami M, Zhao Y, Eriksson JE, Tsuruo T and Rangnekar
VM: Binding and phosphorylation of par-4 by akt is essential for
cancer cell survival. Mol Cell. 20:33–44. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El-Guendy N, Zhao Y, Gurumurthy S,
Burikhanov R and Rangnekar VM: Identification of a unique core
domain of par-4 sufficient for selective apoptosis induction in
cancer cells. Mol Cell Biol. 23:5516–5525. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu G, Ahmed M, Sells SF, Mohiuddin M,
Weinstein MH and Rangnekar VM: Mutually exclusive expression
patterns of Bcl-2 and Par-4 in human prostate tumors consistent
with down-regulation of Bcl-2 by Par-4. Oncogene. 18:623–631. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheema SK, Mishra SK, Rangnekar VM, Tari
AM, Kumar R and Lopez-Berestein G: Par-4 transcriptionally
regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J
Biol Chem. 278:19995–20005. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Diaz-Meco MT and Abu-Baker S: The
Par-4/PTEN connection in tumor suppression. Cell Cycle.
8:2518–2522. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goswami A, Ranganathan P and Rangnekar VM:
The phos-phoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective
therapeutic target. Cancer Res. 66:2889–2892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nalca A, Qiu SG, El-Guendy N, Krishnan S
and Rangnekar VM: Oncogenic Ras sensitizes cells to apoptosis by
Par-4. J Biol Chem. 274:29976–29983. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Diaz-Meco MT, Lallena MJ, Monjas A, Frutos
S and Moscat J: Inactivation of the inhibitory kappaB protein
kinase/nuclear factor kappaB pathway by Par-4 expression
potentiates tumor necrosis factor alpha-induced apoptosis. J Biol
Chem. 274:19606–19612. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malik SN, Brattain M, Ghosh PM, Troyer DA,
Prihoda T, Bedolla R and Kreisberg JI: Immunohistochemical
demonstration of phospho-Akt in high Gleason grade prostate cancer.
Clin Cancer Res. 8:1168–1171. 2002.PubMed/NCBI
|
|
35
|
Joshi J, Fernandez-Marcos PJ, Galvez A,
Amanchy R, Linares JF, Duran A, Pathrose P, Leitges M, Cañamero M,
Collado M, et al: Par-4 inhibits Akt and suppresses Ras-induced
lung tumorigenesis. EMBO J. 27:2181–2193. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barkett M and Gilmore TD: Control of
apoptosis by Rel/NF-kappaB transcription factors. Oncogene.
18:6910–6924. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Salvesen GS and Dixit VM: Caspase
activation: The induced-proximity model. Proc Natl Acad Sci USA.
96:10964–10967. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ivana Scovassi A and Diederich M:
Modulation of poly(ADP-ribo-sylation) in apoptotic cells. Biochem
Pharmacol. 68:1041–1047. 2004. View Article : Google Scholar : PubMed/NCBI
|
